Cargando…
Tacrolimus rescue therapy for severe respiratory failure in the anti-synthetase syndrome
Interstitial lung disease (ILD) is the major determinant of morbidity and mortality in the anti-synthetase syndrome (ASS). The therapeutic efficacy of corticosteroids for the ILD component is limited; hence, additional immunosuppressive and immunomodulatory therapies have been tried with a modicum o...
Autores principales: | Rigby, Amy L, Plit, Marshall, Glanville, Allan R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184510/ https://www.ncbi.nlm.nih.gov/pubmed/25473571 http://dx.doi.org/10.1002/rcr2.52 |
Ejemplares similares
-
ECMO‐dependent respiratory failure after snorting speed associated with anti‐GBM antibodies
por: De Rosa, Nicholas, et al.
Publicado: (2015) -
Fulminant Respiratory Failure Caused by Anti-asparaginyl tRNA Synthetase (Anti-KS) Antibody Syndrome-related Interstitial Lung Disease
por: Oda, Naohiro, et al.
Publicado: (2022) -
Novel case of anti-synthetase syndrome
por: Kapoor, Aniruddh, et al.
Publicado: (2018) -
CNS Vasculitis in Anti-Synthetase Syndrome
por: Shipa, Muhammad, et al.
Publicado: (2019) -
Interstitial Lung Disease in Anti-Synthetase Syndrome
por: Kourkouni, Evangelia, et al.
Publicado: (2019)